First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
Biomed Pharmacother. 2021 Jun;138:111480. doi: 10.1016/j.biopha.2021.111480. Epub 2021 Mar 26.
Osteogenesis and angiogenesis acts as an essential role in repairing large tibial defects (LTDs). Total flavonoids of rhizoma drynariae (TFRD), a traditional Chinese medicinal herb, is reported to show anabolic effects on fracture healing. However, whether TFRD could improve the bone formation and angiogenesis in LTDs remains unknown. The purpose of this study was to evaluate the effect of TFRD on bone formation and angiogenesis in LTDs in distraction osteogenesis (DO). Using a previously established fracture model, LTD rats was established with circular external fixator (CEF). All rats then randomly divided into TFRD low dosage group (with DO), TFRD medium dosage group (with DO), TFRD high dosage group (with DO), model group (with DO) and blank group (without DO). Twelve weeks after treatment, according to X-ray and Micro-CT, TFRD groups (especially in medium dosage group) can significantly promote the formation of a large number of epiphyses and improve new bone mineralization compared with model group, and the results of HE and Masson staining and in vitro ALP level of BMSC also demonstrated the formation of bone matrix and mineralization in the TFRD groups. Also, angiographic imaging suggested that total flavonoids of TFRD was able to promote angiogenesis in the defect area. Consistently, TFRD significantly increased the levels of BMP-2, SMAD1, SMAD4, RUNX-2, OSX and VEGF in LTD rats based on ELISA and Real-Time PCR. In addition, we found that ALP activity of TFRD medium dosage group reached a peak after 10 days of induction through BMSC cell culture in vitro experiment. TFRD promoted bone formation in LTD through activation of BMP-Smad signaling pathway, which provides a promising new strategy for repairing bone defects in DO surgeries.
骨生成和血管生成在修复大胫骨缺损(LTDs)中起着重要作用。传统中药密骨灵总黄酮(TFRD)被报道具有促进骨折愈合的合成代谢作用。然而,TFRD 是否能改善 LTDs 中的骨形成和血管生成尚不清楚。本研究旨在评估 TFRD 在牵张成骨(DO)中对 LTDs 骨形成和血管生成的影响。使用先前建立的骨折模型,使用环形外固定器(CEF)建立 LTD 大鼠模型。所有大鼠随后随机分为 TFRD 低剂量组(DO)、TFRD 中剂量组(DO)、TFRD 高剂量组(DO)、模型组(DO)和空白组(无 DO)。治疗 12 周后,根据 X 射线和 Micro-CT,TFRD 组(特别是中剂量组)与模型组相比,能明显促进大量骺的形成和改善新骨矿化,HE 和 Masson 染色以及体外 ALP 水平的 BMSC 结果也表明 TFRD 组形成了骨基质和矿化。此外,血管造影成像表明 TFRD 总黄酮能够促进缺损区域的血管生成。一致地,ELISA 和 Real-Time PCR 结果表明,TFRD 显著增加了 LTD 大鼠中 BMP-2、SMAD1、SMAD4、RUNX-2、OSX 和 VEGF 的水平。此外,我们发现通过体外 BMSC 细胞培养的实验,TFRD 中剂量组在 10 天诱导后达到 ALP 活性的峰值。TFRD 通过激活 BMP-Smad 信号通路促进 LTD 中的骨形成,为 DO 手术中修复骨缺损提供了一种有前途的新策略。